217 related articles for article (PubMed ID: 30048651)
1. Emerging Role of IL-4-Induced Gene 1 as a Prognostic Biomarker Affecting the Local T-Cell Response in Human Cutaneous Melanoma.
Ramspott JP; Bekkat F; Bod L; Favier M; Terris B; Salomon A; Djerroudi L; Zaenker KS; Richard Y; Molinier-Frenkel V; Castellano F; Avril MF; Prévost-Blondel A
J Invest Dermatol; 2018 Dec; 138(12):2625-2634. PubMed ID: 30048651
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 4-Induced Gene 1 as an Emerging Regulator of B-Cell Biology and its Role in Cutaneous Melanoma.
Prevost-Blondel A; Richard Y
Crit Rev Immunol; 2019; 39(1):39-57. PubMed ID: 31679193
[TBL] [Abstract][Full Text] [Related]
3. An Overview of l-Amino Acid Oxidase Functions from Bacteria to Mammals: Focus on the Immunoregulatory Phenylalanine Oxidase IL4I1.
Castellano F; Molinier-Frenkel V
Molecules; 2017 Dec; 22(12):. PubMed ID: 29206151
[TBL] [Abstract][Full Text] [Related]
4. The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.
Salmi S; Lin A; Hirschovits-Gerz B; Valkonen M; Aaltonen N; Sironen R; Siiskonen H; Pasonen-Seppänen S
BMC Cancer; 2021 May; 21(1):641. PubMed ID: 34051744
[TBL] [Abstract][Full Text] [Related]
5. IL4I1: Key immunoregulator at a crossroads of divergent T-cell functions.
Romagnani S
Eur J Immunol; 2016 Oct; 46(10):2302-2305. PubMed ID: 27726138
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients.
Messaoudene M; Périer A; Fregni G; Neves E; Zitvogel L; Cremer I; Chanal J; Sastre-Garau X; Deschamps L; Marinho E; Larousserie F; Maubec E; Avril MF; Caignard A
PLoS One; 2015; 10(7):e0133363. PubMed ID: 26218530
[TBL] [Abstract][Full Text] [Related]
7. The immunosuppressive enzyme IL4I1 promotes FoxP3(+) regulatory T lymphocyte differentiation.
Cousin C; Aubatin A; Le Gouvello S; Apetoh L; Castellano F; Molinier-Frenkel V
Eur J Immunol; 2015 Jun; 45(6):1772-82. PubMed ID: 25778793
[TBL] [Abstract][Full Text] [Related]
8. Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients.
Speeckaert R; Vermaelen K; van Geel N; Autier P; Lambert J; Haspeslagh M; van Gele M; Thielemans K; Neyns B; Roche N; Verbeke N; Deron P; Speeckaert M; Brochez L
Eur J Cancer; 2012 Sep; 48(13):2004-11. PubMed ID: 22033321
[TBL] [Abstract][Full Text] [Related]
9. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.
Miracco C; Mourmouras V; Biagioli M; Rubegni P; Mannucci S; Monciatti I; Cosci E; Tosi P; Luzi P
Oncol Rep; 2007 Nov; 18(5):1115-22. PubMed ID: 17914561
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
11. Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients.
Massi D; Romano E; Rulli E; Merelli B; Nassini R; De Logu F; Bieche I; Baroni G; Cattaneo L; Xue G; Mandalà M
Eur J Cancer; 2017 Jun; 78():70-81. PubMed ID: 28412591
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of tumor-infiltrating Foxp3+ T-cell subpopulations in metastatic melanoma.
Knol AC; Nguyen JM; Quéreux G; Brocard A; Khammari A; Dréno B
Exp Dermatol; 2011 May; 20(5):430-4. PubMed ID: 21410773
[TBL] [Abstract][Full Text] [Related]
13. Phase- and stage-related proportions of T cells bearing the transcription factor FOXP3 infiltrate primary melanoma.
De Panfilis G; Campanini N; Santini M; Mori G; Tognetti E; Maestri R; Lombardi M; Froio E; Ferrari D; Ricci R
J Invest Dermatol; 2008 Mar; 128(3):676-84. PubMed ID: 17851585
[TBL] [Abstract][Full Text] [Related]
14. The IL4I1 Enzyme: A New Player in the Immunosuppressive Tumor Microenvironment.
Molinier-Frenkel V; Prévost-Blondel A; Castellano F
Cells; 2019 Jul; 8(7):. PubMed ID: 31330829
[TBL] [Abstract][Full Text] [Related]
15. IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma.
Bod L; Lengagne R; Wrobel L; Ramspott JP; Kato M; Avril MF; Castellano F; Molinier-Frenkel V; Prévost-Blondel A
Oncoimmunology; 2017; 6(3):e1278331. PubMed ID: 28405502
[TBL] [Abstract][Full Text] [Related]
16. Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma.
Falkenius J; Johansson H; Tuominen R; Frostvik Stolt M; Hansson J; Egyhazi Brage S
BMC Cancer; 2017 Aug; 17(1):584. PubMed ID: 28851300
[TBL] [Abstract][Full Text] [Related]
17. CD8⁺ tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma.
Fujii H; Arakawa A; Utsumi D; Sumiyoshi S; Yamamoto Y; Kitoh A; Ono M; Matsumura Y; Kato M; Konishi K; Shiga T; Sano S; Sakaguchi S; Miyagawa-Hayashino A; Takahashi K; Uezato H; Miyachi Y; Tanioka M
Int J Cancer; 2014 May; 134(10):2393-402. PubMed ID: 24243586
[TBL] [Abstract][Full Text] [Related]
18. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
[TBL] [Abstract][Full Text] [Related]
19. Intratumour microbiome associated with the infiltration of cytotoxic CD8+ T cells and patient survival in cutaneous melanoma.
Zhu G; Su H; Johnson CH; Khan SA; Kluger H; Lu L
Eur J Cancer; 2021 Jul; 151():25-34. PubMed ID: 33962358
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas.
Chłopik A; Selim MA; Peng Y; Wu CL; Tell-Marti G; Paral KM; Shalin SC; Kraft S; Hsu CK; Shea CR; Puig S; Fernandez-Figueras MT; Biernat W; Ryś J; Marszalek A; Hoang MP
Hum Pathol; 2018 Mar; 73():176-183. PubMed ID: 29307625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
